Search research articles
Contact Us
Filters
Showing results (171-180 of 232) with videos related to
Page
of 24
Sort By:
Journal of the National Cancer Institute
|
October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2
Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2011
Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group
Amit M Oza, Laurie Elit, Ming-Sound Tsao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Cancer Chemotherapy and Pharmacology
|
April 17, 2008
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine
Smitha S Krishnamurthi, Joanna M Brell, Charles L Hoppel, et al.
Investigational New Drugs
|
July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
Ivan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group
Ramesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.
Cancer
|
April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors
Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function
Chris H Takimoto, Martin A Graham, Graham Lockwood, et al.
Molecular Cancer Therapeutics
|
February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
James Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 232) with videos related to
Sort By:
Page
of 24
Journal of the National Cancer Institute
|
October 21, 2004
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2
Brigitte C Widemann, Frank M Balis, Aiman Shalabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2011
Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group
Amit M Oza, Laurie Elit, Ming-Sound Tsao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Cancer Chemotherapy and Pharmacology
|
April 17, 2008
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine
Smitha S Krishnamurthi, Joanna M Brell, Charles L Hoppel, et al.
Investigational New Drugs
|
July 18, 2013
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
Ivan Diaz-Padilla, Hal Hirte, Amit M Oza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group
Ramesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.
Cancer
|
April 12, 2023
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors
Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function
Chris H Takimoto, Martin A Graham, Graham Lockwood, et al.
Molecular Cancer Therapeutics
|
February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
James Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Page
of 24